Three intense days marked by curiosity, persistence, and a drive to transform science into real change in the treatment of serious diseases.
Here are a few highlights from the symposium for those who couldn’t attend:
- Craig Mello on RNA interference as the cell’s ancient information defense – and why we are only beginning to grasp its potential.
- Katherine High shares her long journey in gene therapy, from early setbacks to life-changing treatments for patients with hemophilia and inherited eye diseases.
- Jan M. Lundberg and Mikael Dolsten in conversation about scientific leadership, drug development, and the future of pharmacology in an era of AI and rapid change.
A quick word with Lars Grundemar …
What is your personal takeaway from the Lund Spring Symposium 2025?
– Definitely a great deal of energy and inspiration from world-leading academic researchers and successful entrepreneurs who have made important progress in the treatment of serious diseases.
Pharmacology was highlighted during the symposium as a truly interdisciplinary field of our time – how do you see it developing in the years ahead?
– All modern medical research aimed at new treatment principles requires collaboration across disciplines – ranging from pathology, physiology, and biochemistry to the fundamental principles of both conventional drugs – the so-called small molecules – as well as new types of medicines such as nucleotides, and larger molecules like antibodies. All these different modalities need to be understood from a modern pharmacological perspective: both how the molecules affect the body and how the body processes them. Together, these aspects represent the new pharmacology of the 21st century.